A Multicenter Study of Belantamab Mafodotin and Mezigdomide in Patients With Relapsed Multiple Myeloma | MicrobiomeTrials← Back to trialsNCT07612787
A Multicenter Study of Belantamab Mafodotin and Mezigdomide in Patients With Relapsed Multiple Myeloma
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-06-01Est. Completion: 2028-01-01
Enrollment target: 44 participants Locations- Centre Hospitalier Universitaire, Amiens, France
- Centre Hospitalier Universitaire, Angers, France
- Centre Hospitalier Universitaire, Annecy, France
- Centre Hospitalier D'Argenteuil, Argenteuil, France
- Centre Hospitalier de La Cote Basque, Bayonne, France
- Institut Bergonié, Bordeaux, France
- Centre Hospitalier Universitaire, Brest, France
- Centre Hospitalier Universitaire, Caen, France
- Centre Hospitalier Universitaire, Clermont-Ferrand, France
- Centre Hospitalier Universitaire, Dijon, France
- Centre Hospitalier Universitaire, Grenoble, France
- Centre Hospitalier, Le Mans, France
- Centre Hospitalier Universitaire, Lille, France
- Centre Hospitalier Universitaire, Limoges, France
- HCL Lyon-Sud, Lyon, France
- Centre Hospitalier Regional Et Universitaire, Nancy, France
- Hôpital Privé de Confluent, Nantes, France
- Centre Hospitalier Universitaire, Nantes, France
- Centre Hospitalier Universitaire, Nice, France
Other microbiome trials you might be interested in
Multiple MyelomaRelapsed and/or Refractory Multiple Myeloma (RRMM)
Background:
Multiple myeloma (MM) is a type of blood cancer that affects a person s immunity. MM returns after treatmen…
Bethesda, United StatesCompleted Jan 1, 2033
Malignancy, HematologicNeoplasms, HematologicNeoplasms, HematopoieticBlood CancerHematological NeoplasmsHematopoietic Malignancies
Centre Hospitalier Universitaire, Orléans, FranceCentre Hospitalier Universitaire, Paris, FranceHopital St Antoine, Paris, FranceAPHP - La Pitié Salpétrière, Paris, FranceHopital Cochin, Paris, FranceCentre Hospitalier de Poitiers, Poitiers, FranceCentre Henri Becquerel, Rouen, FranceCentre Hospitalier Universitaire, Saint-Etienne, FranceICANS, Strasbourg, FranceIUCT, Toulouse, FranceCentre Hospitalier Universitaire, Tours, FranceDysmyelopoietic Syndromes
Hematopoetic Myelodysplasia
Myeloid Leukemia, Acute
Nonlymphoblastic Leukemia, Acute
Leukemia, Lymphocytic, Acute
Background:
Blood cancers (such as leukemias) can be hard to treat, especially if they have mutations in the TP53 or RA…
Bethesda, United StatesEst. completion Apr 30, 2029